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To the Editor,
Food allergy is a potentially life‐threatening disease with a detri-
mental effect on the quality of life of caregivers and children.1
Although many different types of food have been identified as
potential elicitors of allergic reactions, only a small number of these
foods cause the majority of reactions.2
Food consists of a complex mixture of nutrient and non‐nutrient
components and their molecular interactions, which are known as
the food matrix. Individual matrix components, or the matrix as a
whole, may interact with a food allergen and may influence the clini-
cal response to that allergen.3 However, data on this role of the food
matrix in the clinical allergic response are scarce.
Establishing the influence of the food matrix is important because
allergens are not ingested in a pure state. The main influences of the
food matrix on an allergic reaction are considered to be caused by
changes in allergen bioavailability and release, digestibility, and conse-
quent interactions with the immune system.3 The fat content of the
food matrix has previously been shown to have an impact on this
bioavailability of the allergenic protein in vitro for peanuts.4 Thus, the
food matrix could influence the uptake of allergens from food, and as
a consequence confound the relationship between exposure to these
allergens and the resultant clinical reaction.
A case series of double‐blind, placebo‐controlled food challenges
(DBPCFC) with four peanut allergic patients by Grimshaw et al, sug-
gested that a lower fat content of the peanut matrix reduced the
amount of peanut required to elicit a reaction in three of the four
subjects. These three subjects also had more severe symptoms in
the food challenge using a high‐fat peanut matrix.5 However, due to
the small number of subjects, only a descriptive evaluation of the
results was possible and thus no definite conclusions could be drawn
from this study.
So far, the current evidence suggests that the qualities of the
food matrix may play an important role in the severity of the allergic
reaction. However, to the best of the authors’ knowledge, no previ-
ous study has shown an association between the fat content of a
matrix and the clinical allergic response. A previous study from our
centre with hen's egg challenges failed to find such an association.6
The aim of this study was to examine possible matrix effects of a
high‐ and low‐fat content food matrix during DBPCFCs with peanut
by comparing the severity and eliciting doses (EDs) of challenge
reactions.
All positive diagnostic peanut DBPCFCs performed at the Bea-
trix's Children's Hospital in the University Medical Center Groningen
between 2002 and 2014 were included. Food challenges were
excluded if they were performed with any other than the two most
frequently used recipes (11 cases excluded). In children with repeated
DBPCFCs, only the first test was included (37 cases excluded). Four-
teen cases were excluded because the challenge recipe was not
specified.
DBPCFCs were performed as part of routine clinical care and
according to previously published protocols.7,8 The recipes used
were peanut in cookies and peanut in gingerbread, with a fat con-
tent of 23.9% and 5.9%, respectively. The contents of the recipes
are shown in Table 1. The dosing scheme for the two recipes was
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identical. The recipe used in the DBPCFC was based on the patient's
own preference. The food challenge was deemed positive when
objective and/or repeated subjective allergic symptoms were
observed on the active day.
The severity of reactions during the DBPCFC was determined by
scoring the symptoms according to van der Zee et al,9 with a sever-
ity index ranging from 0 to 12. A second scoring system, published
by Astier et al10 was used for sensitivity analysis.
The influence of the matrix on the severity of the challenge reac-
tion and ED was analysed by linear regression analysis, with correc-
tion for possible confounders. A variable was considered a
confounder when it changed the beta coefficient by more than 10%.
The alpha significance level was set at 0.05. The level of sIgE, ED,
and reaction time during the DBPCFC was logarithmically trans-
formed to normalize the residuals.
Two hundred and ten peanut allergic children were included in the
analysis. Of these patients, 69 children ingested peanut in gingerbread,
and 141 children ingested peanut in cookie during the active day of
the DBPCFC. The included children were predominately boys (57.6%)
and had a median age of 7.4 years with an interquartile range of 5.2‐
12.0 years. A substantial proportion of the children suffered from
additional atopic disease. The median level of peanut specific IgE was
15.4 kU/L with an interquartile range of 3.9‐60.8 kU/L. For further
demographics according to the recipe used, see Table 2.
All assumptions of the linear regression analysis were met
when using the scoring system by van der Zee et al However,
when using the scoring system by Astier et al, the assumption of
normally distributed residuals was not fulfilled. Thus, the final anal-
ysis was performed using the scoring system by van der Zee et al
only.
Linear regression analysis showed that children challenged with
the high‐fat recipe, peanut in cookies, had more severe reactions
during the DBPCFC (B = 0.77, 95%CI: 0.06‐1.49, P-value= 0.03),
compared to children challenged with the low‐fat recipe, peanut in
TABLE 1 The contents of the peanut recipes used during DBPCFCs
Peanut in gingerbread Peanut in cookie
Oven cooking temperature and time 160°C, 22 min 170°C, 25 min
Fat content 5.9% 23.9%
Ingredients Self‐rising wheat flour 40 g Cane sugar 25 g
Rice milk 35 g Dairy‐free margarine 20 g
Caster sugar 29 g Whole wheat flour 14 g
Peanut flour (defatted) 8 g All‐purpose wheat flour 14 g
Dairy‐free margarine 5 g Coconut 10 g
Cinnamon, coriander, nutmeg, cloves, ginger, cardamom Wheat germs 5 g
Peanut flour (defatted) 2 g
Total 117 g 90 g
TABLE 2 Differences in demographics and reaction parameters according to the recipe used analysed by linear or logistic regression
Recipe used








Age, y, median (IQR) 8.4 (5.2‐12.8) 7.3 (5.3‐11.9) 0.45 −0.46 −1.68‐0.75





Asthma, n (%) 35.0 (50.7) 98.0 (69.5) 0.01 0.44 0.24‐0.81
Atopic dermatitis, n (%) 62.0 (89.9) 128.0 (90.8) 0.93 1.05 0.38‐2.90
Allergic rhinoconjunctivitis, n (%) 32.0 (46.4) 71.0 (50.4) 0.59 0.85 0.48‐1.52
Level of peanut sIgE, kU/L, median (IQR)* 13.6 (5.1‐43.2) 15.6 (3.2‐89.3) 0.73 0.07 −0.34‐0.49
Eliciting dose, mg protein, median (IQR)* 70.0 (3.5‐350.0) 70.0 (14.0‐350.0) 0.45 0.22 −0.35‐0.79
Reaction time DBPCFC, min, median (IQR)* 15.0 (5.5‐40.0) 15.0 (5.0‐42.0) 0.97 0.01 −0.33‐0.35
Severity of DBPCFC reaction, score, median (IQR) 3.0 (3.0‐5.0) 4.0 (3.0‐6.0) 0.03 0.77 0.06‐1.49
Severity of accidental reaction by history, score median (IQR) 2.0 (0.5‐4.0) 2.0 (0.0‐6.0) 0.44 0.35 −0.54‐1.23
The high‐fat recipe was used as reference. All these demographics were investigated as possible confounders for the relationship between the recipe
and the severity of the challenge reaction and ED (for details, see statistical paragraph) logarithmically transformed.
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gingerbread. However, there was no significant difference in the ED
for the high‐ and low‐fat recipes (B = 0.22, 95%CI: −0.35-0.79,
P-value= 0.45). No confounders were identified in these relation-
ships, including asthma.
The results of this study show that children receiving peanut in a
high‐fat matrix during an oral food challenge have more severe reac-
tions compared to children undergoing this test with a low‐fat
matrix. This supports the role of the food matrix as a factor which
may enhance the severity of both diagnostic challenge reactions as
well as accidental reactions.
Our results showed no statistically significant difference in elicit-
ing dose between the high‐ and low‐fat recipes. This is at variance
for what could be expected for foods with a high‐fat content,11 and
reasons for this difference are not known. It should be noted, how-
ever, that reaction severity and eliciting dose are not closely
related,,12 so that changes in one need not be accompanied by
changes in the other.
In a previous study by Libbers et al,6 no matrix effect was shown
for two different matrices used during DBPCFC with hen's egg. This
suggests that matrix effects differ per type of allergenic food. Lib-
bers et al suggested a possible explanation for differences in matrix
effect between peanut and hen's egg to be the fat content of the
allergenic food itself. Thus, the inherent difference in fat content
between peanut and hen's egg may influence to what extent compo-
nents of the allergenic food may dissolve in the food matrix in ques-
tion and may therefore affect the rate of allergen release and
bioavailability to the immune system.6
A limitation of this study is that patients were not randomized to
the two recipes. The included children were allowed to choose
which one of the two recipes they preferred, as recipe diversity is
important to increase test compliance and avoid undue selection
bias. Although a prospective, randomized study would be method-
ologically superior, it would be difficult, time‐consuming and expen-
sive to perform, and could result in a highly selected population of
children willing and able to eat either recipe.
Another limitation of this study is that the two recipes used
differed in other ways than the fat content. Moreover, the low‐fat
recipe had a higher concentration of peanut per gram of food
matrix. However, it was the children receiving the high‐fat matrix
(with a lower peanut allergen concentration) that experienced more
severe reactions, and thus, this does not seem to explain our
results. Differences in the cooking time and temperature may also
have accounted for differences in the resultant reactions, although
these differences were small (see Table 1). Finally, some of the
symptoms may have been caused by the higher fat content itself
rather than a matrix effect on peanut. As such symptoms are mild,
they would skew the data to showing milder reactions in the high‐
fat matrix group, which is contrary to what we observed. Thus, it
is unlikely that such symptoms may account for the differences
reported here.
In conclusion, this study shows a matrix effect for peanut, seen
in differences in the severity of reactions in oral food challenges.
Consequently, to be able to compare the results of oral food
challenges in different patient groups or from different centres, the
development of standardized food challenge materials may be neces-
sary. Moreover, matrix effects could possibly influence accidental
reactions to peanut and adverse events during peanut immunother-
apy. This may be important from a regulatory perspective as well as
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